After signing up, you'll start to receive regular news updates from us.
deCODE biostructures Expands Collaboration with InterMune

Complete the form below to unlock access to ALL audio articles.
deCODE biostructures, Inc. announces the initiation of a third research project with InterMune, Inc. Under the research agreement, deCODE biostructures will conduct screening of its Fragments of Life™ library against an InterMune target.
The research fee and milestone-based research collaboration will utilize deCODE's proprietary Fragments of Life™ technology and crystallographic methods to enable identification of new chemical intellectual property for small molecule inhibitors of InterMune's drug target.